SCHEMBL9780216

SCHEMBL9780216

CCCc1c(OCCCSc2ccc(CC(SCc3nnn[nH]3)C(C)C(=O)OC)cc2)ccc(C(C)=O)c1O.[NaH]

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 5/20 0.49
CYSLTR1 Q9Y271 5/20 0.49
PPARG P37231 4/20 0.46
PPARD Q03181 4/20 0.46
PPARA Q07869 4/20 0.46
LMNA P02545 2/20 0.43
MEN1 O00255 1/20 0.43
GLA P06280 1/20 0.43
CYP3A4 P08684 1/20 0.43
ALOX5 P09917 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
GRM2 Q14416 8/20 0.41
CYP1A2 P05177 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9780265 0.92 CYSLTR2 (0.52) CYSLTR2CYSLTR1PPARGPPARDPPARA
SCHEMBL9780267 0.85 CYSLTR2 (0.57) CYSLTR2CYSLTR1PPARGPPARDPPARA
SCHEMBL9780317 0.83 CYSLTR2 (0.55) CYSLTR2CYSLTR1PPARGPPARDPPARA
SCHEMBL9780211 0.82 CYSLTR2 (0.56) CYSLTR2CYSLTR1PPARGPPARDPPARA
SCHEMBL9863287 0.81 CYSLTR2 (0.57) CYSLTR2CYSLTR1PPARGPPARDPPARA
SCHEMBL9780487 0.81 CYSLTR2 (0.62) CYSLTR2CYSLTR1PPARGPPARDPPARA
SCHEMBL9780329 0.81 CYSLTR2 (0.66) CYSLTR2CYSLTR1PPARGPPARDPPARA
SCHEMBL9780312 0.81 CYSLTR2 (0.66) CYSLTR2CYSLTR1PPARGPPARDPPARA
SCHEMBL9780260 0.80 CYSLTR2 (0.67) CYSLTR2CYSLTR1PPARGPPARDPPARA
SCHEMBL9780328 0.79 CYSLTR2 (0.57) CYSLTR2CYSLTR1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0206741-B1 LEUKOTRIENE ANTAGONISTS MERCK FROSST CANADA INC. (CA) 1991-04-10 EP claimed
US-4990526-A Skin disorders, antiallergens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1991-02-05 US claimed
EP-0206741-A2 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1986-12-30 EP claimed